endo-DMTx
In partnership with the University of Florida, our study takes a foundational step toward endo-DMTx by isolating and characterizing an internal “switch” that regulates DMT production in the brain.
DMT Biosynthesis
Psychedelic Neuroscience
Endo‑DMTx: Unlocking the Brain’s Inner Technology
Extended-state DMTx technology is on the brink of transforming mental health therapies and redefining our exploration of DMT realms. But what if we could eliminate external substances and needles entirely, harnessing instead our body’s natural ability to produce DMT?
We’ve known since the 1950s that DMT naturally occurs in human blood and cerebrospinal fluid. Recent research shows that DMT levels in mammalian brains rival key neurotransmitters like serotonin and dopamine, indicating it plays an essential role in brain function. Yet, we still have minimal understanding of how DMT production is regulated within the brain.
Imagine being able to “hack” our endogenous DMT system—switching DMT production on and off at will, without invasive infusion methods. This is the future we call endo-DMTx. To get there, we must first pinpoint the internal mechanisms controlling DMT biosynthesis.
Our groundbreaking partnership with the University of Florida is poised to take that crucial first step. Together, we aim to identify and characterize the brain’s internal “switch” that governs natural DMT production. Mastering this switch could unlock unprecedented control over our mental states and therapeutic possibilities.
